A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Efficacy Study of SYN118 as Adjunctive Therapy in Subjects with Parkinson's Disease
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2012
At a glance
- Drugs Nitisinone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 24 May 2011 Primary endpoint 'Unified Parkinson's Disease Rating Scale motor function' not met.
- 24 May 2011 Status changed from recruiting to completed.
- 05 Oct 2010 New trial record